Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | BCA101 |
Trade Name | |
Synonyms | BCA-101|BCA 101 |
Drug Descriptions |
BCA101 is a monoclonal antibody that binds to both EGFR and TGFB and leads to inhibition of downstream signaling, and may lead to inhibition of tumor cell proliferation (NCI Drug Dictionary). |
DrugClasses | EGFR Antibody 39 TGFB (Pan) Antibody 4 |
CAS Registry Number | NA |
NCIT ID | C173165 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BCA101 | BCA101 | 0 | 1 |
BCA101 + Pembrolizumab | BCA101 Pembrolizumab | 0 | 1 |